BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37163963)

  • 1. The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    Elasifer H; Amukwaya MMN; Bhatia R; Cuschieri K; Gregory JM
    J Clin Virol; 2023 Jul; 164():105469. PubMed ID: 37163963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating HPV DNA in HPV-associated cancers.
    Lin G; Li J
    Clin Chim Acta; 2023 Mar; 542():117269. PubMed ID: 36841427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptima Human Papillomavirus E6/E7 mRNA Test Results Strongly Associated With Risk for High-Grade Cervical Lesions in Follow-Up Biopsies.
    Ge Y; Christensen P; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR
    J Low Genit Tract Dis; 2018 Jul; 22(3):195-200. PubMed ID: 29543688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of cell-free human papillomavirus DNA as a biomarker in cervical cancer and other HPV-associated tumors: A review.
    Sivars L; Palsdottir K; Crona Guterstam Y; Falconer H; Hellman K; Tham E
    Int J Cancer; 2023 Jun; 152(11):2232-2242. PubMed ID: 36274628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
    de Sanjosé S; Bruni L; Alemany L
    Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Balachandra S; Kusin SB; Lee R; Blackwell JM; Tiro JA; Cowell LG; Chiang CM; Wu SY; Varma S; Rivera EL; Mayo HG; Ding L; Sumer BD; Lea JS; Bagrodia A; Farkas LM; Wang R; Fakhry C; Dahlstrom KR; Sturgis EM; Day AT
    Cancer; 2021 Mar; 127(6):850-864. PubMed ID: 33270909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
    Karimi A; Jafari-Koshki T; Zehtabi M; Kargar F; Gheit T
    Cancer Med; 2023 Sep; 12(17):17592-17602. PubMed ID: 37492996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Gilbert DC; Wakeham K; Langley RE; Vale CL
    Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.
    Bryan SJ; Lee J; Gunu R; Jones A; Olaitan A; Rosenthal AN; Cutts RJ; Garcia-Murillas I; Turner N; Lalondrelle S; Bhide SA
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
    Han K; Zou J; Zhao Z; Baskurt Z; Zheng Y; Barnes E; Croke J; Ferguson SE; Fyles A; Gien L; Gladwish A; Lecavalier-Barsoum M; Lheureux S; Lukovic J; Mackay H; Marchand EL; Metser U; Milosevic M; Taggar AS; Bratman SV; Leung E
    J Clin Oncol; 2024 Feb; 42(4):431-440. PubMed ID: 37972346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study.
    Dabán-López P; Fernández-Martínez NF; Petrova D; Rodríguez-Barranco M; Jiménez-Moleón JJ; Gutierrez J; Sánchez MJ
    Front Public Health; 2023; 11():1205170. PubMed ID: 37780447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries.
    Jaradi B; Das T; Koo KM
    Anal Chem; 2023 Jul; 95(29):11172-11180. PubMed ID: 37441723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.
    Insinga RP; Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2005; 23(11):1107-22. PubMed ID: 16277547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus and the risk of anogenital cancer].
    Melbye M; Svare EI; Kjaer SK; Frisch M
    Ugeskr Laeger; 2002 Dec; 164(50):5950-3. PubMed ID: 12553119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
    Jeannot E; Latouche A; Bonneau C; Calméjane MA; Beaufort C; Ruigrok-Ritstier K; Bataillon G; Larbi Chérif L; Dupain C; Lecerf C; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Jordanova ES; von der Leyen H; Tran-Perennou C; Legrier ME; Dureau S; Raizonville L; Bello Roufai D; Le Tourneau C; Bièche I; Rouzier R; Berns EMJJ; Kamal M; Scholl S
    Clin Cancer Res; 2021 Nov; 27(21):5869-5877. PubMed ID: 34210686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus: often harmless but in some cases carcinogenic.
    Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC).
    Lee JY; Cutts RJ; White I; Augustin Y; Garcia-Murillas I; Fenwick K; Matthews N; Turner NC; Harrington K; Gilbert DC; Bhide S
    Front Oncol; 2020; 10():505. PubMed ID: 32363162
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.